Market revenue in 2023 | USD 74.8 million |
Market revenue in 2030 | USD 124.6 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Data Sets |
Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Services was the largest segment with a revenue share of 57.62% in 2023. Horizon Databook has segmented the Spain real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
An increase in RWD coupled with growing adoption of RWE solutions is one of the key factors augmenting growth of the RWE solutions market in Spain. Increasing pressure on healthcare facilities to manage the cost and time as well as a large patient pool in the country will further create lucrative growth opportunities for the RWE solutions market.
Moreover, the evolution of IT and rising number of supportive federal initiatives will act as important drivers. RWE solutions are used for a wide variety of purposes, such as drug development lifecycles, reducing cost of clinical trials, shortening development timelines, enhancing regulatory success, and others.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account